Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea flag South Korea · Delayed Price · Currency is KRW
24,750
+100 (0.41%)
Aug 14, 2025, 3:30 PM KST

Onconic Therapeutics Revenue

Onconic Therapeutics had revenue of 9.43B KRW in the quarter ending June 30, 2025, with 249.94% growth. This brings the company's revenue in the last twelve months to 29.43B, up 442.96% year-over-year. In the year 2024, Onconic Therapeutics had annual revenue of 14.84B, down -29.53%.

Revenue (ttm)
29.43B
Revenue Growth
+442.96%
P/S Ratio
9.27
Revenue / Employee
n/a
Employees
n/a
Market Cap
272.72B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202414.84B-6.22B-29.53%
Dec 31, 202321.06B20.96B22,064.25%
Dec 31, 202295.00M35.00M58.33%
Dec 31, 202160.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition